Reliance Capital Expenditures from 2010 to 2025

RELCHEMQ   201.91  3.90  1.97%   
Reliance Chemotex Capital Expenditures yearly trend continues to be very stable with very little volatility. Capital Expenditures is likely to grow to about 1.1 B this year. During the period from 2010 to 2025, Reliance Chemotex Capital Expenditures quarterly data regression pattern had sample variance of 146520.4 T and median of  213,615,428. View All Fundamentals
 
Capital Expenditures  
First Reported
2012-09-30
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
0.0
 
Yuan Drop
 
Covid
Check Reliance Chemotex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reliance Chemotex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 68.2 M, Interest Expense of 236.3 M or Total Revenue of 2.7 B, as well as many indicators such as . Reliance financial statements analysis is a perfect complement when working with Reliance Chemotex Valuation or Volatility modules.
  
This module can also supplement various Reliance Chemotex Technical models . Check out the analysis of Reliance Chemotex Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Reliance Stock

Reliance Chemotex financial ratios help investors to determine whether Reliance Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Reliance with respect to the benefits of owning Reliance Chemotex security.